GlassScriptPhysician profile
Beth Chapman Hanlon
NPI 1801860648
$3,174.90
in general payments reported to CMS, 2019-2025
42 companies · $105 in 2025
The $105 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $624 · 2020: $414 · 2021: $623 · 2022: $594 · 2023: $591 · 2024: $226 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $905 · Education: $16.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $905.30 |
| Education | $16.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $534.04 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $258.29 | 2019-2025 | Gardasil 9, Gardasil, Capvaxive |
| Astellas Pharma US INC | $195.36 | 2019-2024 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.71 | 2019-2023 | Jardiance, Synjardy |
| Amgen INC. | $170.47 | 2019-2022 | |
| Novo Nordisk INC | $170.08 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $133.70 | 2019-2024 | Mounjaro, Trulicity |
| Astrazeneca Pharmaceuticals LP | $132.19 | 2019-2023 | Farxiga |
| Pfizer INC. | $129.58 | 2019-2024 | |
| Glaxosmithkline, LLC. | $128.07 | 2021-2025 | Shingrix, Arexvy |
| Amarin Pharma, INC. | $114.14 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $87.09 | 2019-2023 | Xarelto |
| Sanofi-Aventis U.S. LLC | $82.05 | 2019-2023 | |
| Lucid Diagnostics INC. | $69.32 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $63.99 | 2022-2023 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Hanlon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.